7 / 74
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019
AFRICA
73
AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guide-
line for the prevention, detection, evaluation, and management of
high blood pressure in adults: a report of the American College of
Cardiology/American Heart Association task force on clinical practice
guidelines.
Hypertension
2018;
71
: e13–e115.
9.
SPRINT research group; Wright JT Jr, Williamson JD, Whelton PK,
et al.
A randomized trial of intensive versus standard blood-pressure
control.
N Engl J Med
2015;
373
(22): 2103–2116.
10. Filipovský J, Seidlerová J, Kratochvíl Z,
et al
. Automated compared to
manual office blood pressure and to home blood pressure in hyperten-
sive patients.
Blood Press
2016;
25
(4): 228–234.
11. Okin PM, Kjeldsen SE, Devereux RB. The relationship of all-cause
mortality to average on-treatment systolic blood pressure is significantly
related to baseline systolic blood pressure: implications for interpreta-
tion of the Systolic Blood Pressure Intervention Trial study.
J Hypertens
2018;
36
(4): 916–923.
12. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lower-
ing treatment in hypertension: 8. Outcome reductions vs. discontinu-
ations because of adverse drug events – meta-analyses of randomized
trials.
J Hypertens
2016;
34
(8): 1451–1463.
13. Wokhlu A, Smith SM, Gong Y,
et al
. Mortality implications of
lower DBP with lower achieved systolic pressures in coronary artery
disease: long-term mortality results from the INternational VErapamil-
trandolapril STudy US cohort.
J Hypertens
2018;
36
: 419–427.
14. Bohm M, Schumacher H, Teo KK,
et al
. Achieved blood pres-
sure and cardiovascular outcomes in high-risk patients: results from
ONTARGET and TRANSCEND trials.
Lancet
2017;
389
: 2226–2237.
15. Lonn EM, Bosch J, Lopez-Jaramillo P,
et al.
Blood-pressure lowering
in intermediate-risk persons without cardiovascular disease.
New Engl J
Med
2016;
374
: 2009–2020.
16. Ettehad D, Emdin CA, Kiran A,
et al
. Blood pressure lowering for
prevention of cardiovascular disease and death: a systematic review and
meta-analysis.
Lancet
2016;
387
(10022): 957–967.
17. Brunström M, Carlberg B. Standardization according to blood pressure
lowering in meta-analyses of antihypertensive trials: comparison of
three methodological approaches.
J Hypertens
2018;
36
(1): 4–15.
18. Brunstrom M, Carlberg B. Association of blood pressure lowering
with mortality and cardiovascular disease across blood pressure levels
a systematic review and meta-analysis.
J Am Med Aassoc Intern Med
2018;
178
(1): 28–36.
19. Xie X, Atkins E, Lv J,
et al
. Effects of intensive blood pressure lowering
on cardiovascular and renal outcomes: updated systematic review and
meta-analysis.
Lancet
2016;
387
(10017): 435–443.
20. Bangalore S, Toklu B, Gianos E,
et al
. Optimal systolic blood pressure
target after SPRINT: Insights from a network meta-analysis of rand-
omized trials.
Am J Med
2017;
130
(6): 707–719.
Erratum
In the article
The effect of proximal anastomosis on the expansion rate of a dilated ascending aorta in coronary artery bypass surgery:
a prospective study
by Ahmet Yavuz Balcı, Unsal Vural, Rezan Aksoy, MD Fatih Özdemir, Seçkin Satılmı
ş
, Mehmet Kızılay, Mutlu
Ş
enocak, Huseyin
Ş
a
ş
kın,
İ
lyas Kayacıo
ğ
lu,
İ
brahim Yekeler, published in March/April 2017, we regret listing Dr Özdemir’s name
incorrectly. The correct name is Fatih Özdemir.